Fig. 2.
Mean (SE) increase from baseline of FEV1 after salbutamol 400 μg in the entire group (105 subjects), in 14 patients with preexisting COPD and in 3 asthmatic subjects. ***P < 0.001 vs pre salbutamol.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.